These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28220405)

  • 21. Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.
    Kuehn SC; Koehne T; Cornils K; Markmann S; Riedel C; Pestka JM; Schweizer M; Baldauf C; Yorgan TA; Krause M; Keller J; Neven M; Breyer S; Stuecker R; Muschol N; Busse B; Braulke T; Fehse B; Amling M; Schinke T
    Hum Mol Genet; 2015 Dec; 24(24):7075-86. PubMed ID: 26427607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatment.
    Lizzi Lagranha V; Zambiasi Martinelli B; Baldo G; Ávila Testa G; Giacomet de Carvalho T; Giugliani R; Matte U
    J Mater Sci Mater Med; 2017 Mar; 28(3):43. PubMed ID: 28150116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic Nanoemulsions as a Gene Delivery System: Proof of Concept in the Mucopolysaccharidosis I Murine Model.
    Fraga M; de Carvalho TG; Diel Dda S; Kretzmann Filho NA; Teixeira HF; Matte U
    J Nanosci Nanotechnol; 2015 Jan; 15(1):810-6. PubMed ID: 26328445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series.
    Tebani A; Zanoutene-Cheriet L; Adjtoutah Z; Abily-Donval L; Brasse-Lagnel C; Laquerrière A; Marret S; Chalabi Benabdellah A; Bekri S
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene.
    Anson DS; Bielicki J; Hopwood JJ
    Hum Gene Ther; 1992 Aug; 3(4):371-9. PubMed ID: 1525210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
    Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
    Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
    He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
    Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis.
    Ou L; Przybilla MJ; Whitley CB
    Mol Genet Metab; 2017; 120(1-2):101-110. PubMed ID: 27742266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of mucopolysaccharidosis type I heterozygotes based on the biochemical characteristics of leukocyte alpha-L-iduronidase.
    Mandelli J; Wajner A; Pires RF; Giugliani R; Coelho JC
    Arch Med Res; 2002; 33(1):20-4. PubMed ID: 11825626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1.
    Zahoor MY; Cheema HA; Ijaz S; Anjum MN; Ramzan K; Bhinder MA
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1221-1227. PubMed ID: 31473686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired ion homeostasis as a possible associate factor in mucopolysaccharidosis pathogenesis: transcriptomic, cellular and animal studies.
    Gaffke L; Szczudło Z; Podlacha M; Cyske Z; Rintz E; Mantej J; Krzelowska K; Węgrzyn G; Pierzynowska K
    Metab Brain Dis; 2022 Feb; 37(2):299-310. PubMed ID: 34928474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis status and proliferative activity in mucopolysaccharidosis type I mice tongue mucosa cells.
    Noguti J; Pereira VG; Guilheiro JM; Martins AM; D'Almeida V; Ribeiro DA
    Dent Res J (Isfahan); 2012 Dec; 9(Suppl 1):S69-74. PubMed ID: 23814565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing transfection efficiency of pIDUA/nanoemulsion complexes in a mucopolysaccharidosis type I murine model.
    Fraga M; de Carvalho TG; Bidone J; Schuh RS; Matte U; Teixeira HF
    Int J Nanomedicine; 2017; 12():2061-2067. PubMed ID: 28352175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I.
    Swaroop M; Brooks MJ; Gieser L; Swaroop A; Zheng W
    Hum Mol Genet; 2018 Oct; 27(20):3612-3626. PubMed ID: 30052969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucopolysaccharidosis type I: Identification and characterization of mutations affecting alpha-L-iduronidase activity.
    Lee-Chen GJ; Lin SP; Chen IS; Chang JH; Yang CW; Chin YW
    J Formos Med Assoc; 2002 Jun; 101(6):425-8. PubMed ID: 12189649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I.
    Pan D; Aronovich E; McIvor RS; Whitley CB
    Gene Ther; 2000 Nov; 7(21):1875-83. PubMed ID: 11110421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary α-Iduronidase Activity as a Potential New Biomarker for the Diagnosis and Monitoring the Effect of Therapy in Mucopolysaccharidosis Type I.
    van Doorn J; van den Broek BTA; Geboers AJ; Kuiper GA; Boelens JJ; van Hasselt PM
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1808-1813. PubMed ID: 29906569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors.
    Di Natale P; Di Domenico C; Villani GR; Lombardo A; Follenzi A; Naldini L
    Eur J Biochem; 2002 Jun; 269(11):2764-71. PubMed ID: 12047386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I.
    Suga M; Kondo T; Imamura K; Shibukawa R; Okanishi Y; Sagara Y; Tsukita K; Enami T; Furujo M; Saijo K; Nakamura Y; Osawa M; Saito MK; Yamanaka S; Inoue H
    Stem Cell Res; 2019 Apr; 36():101406. PubMed ID: 30849633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector.
    Kobayashi H; Carbonaro D; Pepper K; Petersen D; Ge S; Jackson H; Shimada H; Moats R; Kohn DB
    Mol Ther; 2005 May; 11(5):776-89. PubMed ID: 15851016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.